Management of acute metabolic decompensation in maple syrup urine disease: guidance based on international clinical practice
Aude Servais, Marie Therese Abi-Wardé, Jean-Baptiste Arnoux, Alberto Burlina, Francois Feillet, Vincenzo Giordano, Nicola Longo, Sufin Yap · 2026
Read Management of acute metabolic decompensation in maple syrup urine disease: guidance based on international clinical practice by Aude Servais, Marie Therese Abi-Wardé, Jean-Baptiste Arnoux, Alberto Burlina, Francois Feillet, Vincenzo Giordano, Nicola Longo, Sufin Yap (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13471534.txt.
Description
Servais and co-authors distilled international expert practice for handling acute metabolic crises in maple syrup urine disease, a rare inherited disorder where the body cannot break down three amino acids. Their 2026 guidance came from eight specialist physicians who met in February 2025 after reviewing four guidelines and 20 further articles.
The danger molecule is leucine, whose buildup drives the crises; the algorithm aims to push plasma leucine below 150 micromoles per liter before discharge while avoiding brain swelling. Steps escalate from stopping protein and flooding in carbohydrate calories to dialysis when neurological signs or stubborn levels demand it. The panel's chief barrier was the lack of ready intravenous amino-acid-free nutrition, a gap a newly EMA-approved formulation should close.
Catalog record
| CREATOR | Aude Servais, Marie Therese Abi-Wardé, Jean-Baptiste Arnoux, Alberto Burlina, Francois Feillet, Vincenzo Giordano, Nicola Longo, Sufin Yap |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 61 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |